UTHR Overview
Upcoming Projects (UTHR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (UTHR)
-
A Second Look: Examining the IPF treatment landscape with a focus on Pliant's bexotegrast, Fibrogen's pamrevlumab, and United Therapeutics' TYVASO (treprostinil)
Tickers: FGEN, PLRX, UTHR
Executed On: Jun 09, 2023 at 03:10 PM EDT -
Examining the IPF treatment landscape with a focus on Pliant's bexotegrast, Fibrogen's pamrevlumab, and United Therapeutics' TYVASO (treprostinil)
Tickers: FGEN, PLRX, UTHR
Executed On: Jun 01, 2023 at 07:00 AM EDT -
A Second View: Delving into the Phase 3 STELLAR trial data released at ACC 2023 on Merck's sotatercept for treating PAH
Tickers: MRK, UTHR
Executed On: Apr 11, 2023 at 06:00 PM EDT -
Delving into the Phase 3 STELLAR trial data released at ACC 2023 on Merck's sotatercept for treating PAH
Tickers: MRK, UTHR
Executed On: Apr 03, 2023 at 05:30 PM EDT -
A look at the use of Treprostinil in PAH and the potential of Liquidia's Yutrepia DPI in the market
Tickers: LQDA, UTHR
Executed On: Aug 10, 2022 at 02:00 PM EDT -
Untangling the LQDA / UTHR IP and Legal Landscape and the implications on YUTREPIA & Tyvaso
Tickers: LQDA, UTHR
Executed On: Jul 28, 2022 at 12:00 PM EDT -
A look at the use of Tyvaso (treprostinil) in PAH and the potential of Tyvaso DPI, in light of its delayed FDA review due to lung safety concerns
Ticker: UTHR
Executed On: May 23, 2022 at 11:00 AM EDT
Upcoming & Overdue Catalysts (UTHR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (UTHR)
-
United Therapeutics' (UTHR) Phase 3 INCREASE Study Of Tyvaso in PH-ILD Data Released
Ticker: UTHR
Occurred on: Feb 24, 2020
Strategic Initiatives (UTHR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
